feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Science / AI Decodes DNA's "Dark Matter" for Disease Insights

AI Decodes DNA's "Dark Matter" for Disease Insights

28 Jan

•

Summary

  • AlphaGenome analyzes up to 1 million DNA letters at once.
  • It predicts how genetic mutations impact gene control.
  • The tool aids in identifying genetic drivers of diseases.
AI Decodes DNA's "Dark Matter" for Disease Insights

Researchers at Google DeepMind have developed AlphaGenome, a novel artificial intelligence tool designed to analyze complex genetic information. This AI can process up to one million letters of DNA code at once, predicting how mutations affect gene regulation.

This capability is crucial for understanding diseases linked to gene control, including heart disease, autoimmune disorders, mental health conditions, and various cancers. AlphaGenome aims to help scientists identify the specific genetic mutations driving these illnesses.

By mapping essential genetic strands for tissue development and pinpointing critical mutations, the tool could underpin new gene therapies. Experts believe AlphaGenome marks a significant advancement in deciphering the non-coding regions of the genome, potentially accelerating fundamental biological understanding and the development of targeted medical interventions.

trending

Ohio snow emergency declared

trending

TikTok down in United States

trending

Andreeva matches Venus Williams' feat

trending

Warrington Hospital baby death

trending

Alexander Zverev advances in Australia

trending

Oilers host Capitals

trending

London celebrates Chinese New Year

trending

Liza Minnelli defends AI use

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
AlphaGenome is an AI tool developed by Google DeepMind that analyzes up to one million DNA letters at once to predict how genetic mutations interfere with gene regulation.
AlphaGenome aids scientists in identifying the genetic mutations that regulate gene activity, which are linked to many common diseases like heart disease, autoimmune disorders, and cancers.
The tool could help map essential genetic code for tissue development, pinpoint mutations driving diseases, and underpin new gene therapies by designing DNA sequences.

Read more news on

Scienceside-arrow

You may also like

Google DeepMind on AI Race: 4-8 Years to AGI

24 Jan • 22 reads

article image

AI's Next Leap: Social Intelligence, Not Just Smarts

23 Jan • 40 reads

article image

DeepMind CEO: China AI Lags Western Labs

21 Jan • 50 reads

article image

ChatGPT Integrates Ads: AI's New Revenue Frontier?

17 Jan • 98 reads

article image

AI Doctors: Accuracy Vague, Trust Fades

16 Jan • 81 reads

article image